肝门部胆管癌的外科治疗策略
Surgical Treatment Strategies for Hilar Cholangiocarcinoma
摘要: 肝门部胆管癌是最常见的胆道恶性肿瘤，目前根治性切除仍然是患者获得长期生存最主要的治疗方法，但其疗效至今无法令人满意，整体预后不佳。近年来，随着对该疾病临床认知、诊断和治疗策略的全面综合发展，使患者的生存期有所提高。但在胆道引流、剩余肝脏体积的处理、门静脉栓塞、手术方式的选择、肝移植等方面仍存在诸多争议。现回顾分析国内外相关文献，就以上争议问题进行综述，为改善患者预后提供参考。
Abstract: Hilar cholangiocarcinoma is the most common malignant tumor of the biliary tract. At present, rad-ical resection is still the most important treatment for long-term survival of patients, but its cura-tive effect is not satisfactory so far, and the overall prognosis is poor. In recent years, with the clini-cal cognition, diagnosis and treatment strategies of the disease comprehensive development of the comprehensive, the survival of patients has improved. However, there are still many controversies in biliary drainage, management of residual liver volume, portal vein embolization, selection of sur-gical methods, and liver transplantation. This paper reviews and analyzes the relevant literature at home and abroad, and summarizes the above controversial issues, so as to provide a reference for improving the prognosis of patients.
文章引用：韩青龙, 樊海宁. 肝门部胆管癌的外科治疗策略[J]. 临床医学进展, 2023, 13(7): 11813-11819. https://doi.org/10.12677/ACM.2023.1371655

参考文献

[1] 张洪义, 刘洋, 邢颖. 肝门部胆管癌的微创手术治疗策略[J]. 中国临床医生杂志, 2020, 48(6): 631-633.
[2] Inchingolo, R., Acquafredda, F., Ferraro, V., et al. (2021) Non-Surgical Treatment of Hilar Cholangio-carcinoma. World Journal of Gastrointestinal Oncology, 13, 1696-1708. [Google Scholar] [CrossRef] [PubMed]
[3] Rerknimitr, R., Angsuwatcharakon, P., Ratanachu, E.K.T., et al. (2013) Asia-Pacific Consensus Recommendations for Endoscopic and Interventional Management of Hilar Cholangio-carcinoma. Journal of Gastroenterology and Hepatology, 28, 593-607. [Google Scholar] [CrossRef] [PubMed]
[4] Mansour, J.C., Aloia, T.A., Crane, C.H., et al. (2015) Hilar Cholangiocar-cinoma: Expert Consensus Statement. HPB (Oxford), 17, 691-699. [Google Scholar] [CrossRef] [PubMed]
[5] Jagannath, P., Dhir, V., Shrikhande, S., Shah, R.C., Mullerpatan, P. and Mohandas, K.M. (2005) Effect of Preoperative Biliary Stenting on Immediate Outcome after Pancreaticoduodenectomy. British Journal of Surgery, 92, 356-361. [Google Scholar] [CrossRef] [PubMed]
[6] Cherqui, D., Benoist, S., Malassagne, B., et al. (2000) Major Liver Resection for Carcinoma in Jaundiced Patients without Preoperative Biliary Drainage. The Archives of Surgery, 135, 302-308. [Google Scholar] [CrossRef] [PubMed]
[7] Figueras, J., Llado, L., Valls, C., et al. (2000) Changing Strategies in Diagnosis and Management of Hilar Cholangiocarcinoma. Liver Transplantation, 6, 786-794. [Google Scholar] [CrossRef] [PubMed]
[8] Rea, D.J., Munoz-Juarez, M., Farnell, M.B., et al. (2004) Major Hepat-ic Resection for Hilar Cholangiocarcinoma: Analysis of 46 Patients. The Archives of Surgery, 139, 514-523. [Google Scholar] [CrossRef] [PubMed]
[9] Lai, E.C., Mok, F.P., Fan, S.T., et al. (1994) Preoperative Endo-scopic Drainage for Malignant Obstructive Jaundice. British Journal of Surgery, 81, 1195-1198. [Google Scholar] [CrossRef] [PubMed]
[10] Pitt, H.A., Gomes, A.S., Lois, J.F., et al. (1985) Does Preoperative Percutaneous Biliary Drainage Reduce Operative Risk or Increase Hospital Cost? Annals of Surgery, 201, 545-553. [Google Scholar] [CrossRef] [PubMed]
[11] Hochwald, S.N., Burke, E.C., Jarnagin, W.R., et al. (1999) Association of Preoperative Biliary Stenting with Increased Postoperative Infectious Complications in Proximal Cholangiocarcinoma. The Archives of Surgery, 134, 261-266. [Google Scholar] [CrossRef] [PubMed]
[12] Mocan, T., Horhat, A., Mois, E., et al. (2021) Endoscopic or Per-cutaneous Biliary Drainage in Hilar Cholangiocarcinoma: When and How? World Journal of Gastrointestinal Oncology, 13, 2050-2063. [Google Scholar] [CrossRef] [PubMed]
[13] Komaya, K., Ebata, T., Yokoyama, Y., et al. (2017) Verification of the Oncologic Inferiority of Percutaneous Biliary Drainage to Endoscopicdrainage: A Propensity Score Matching Analy-sis of Resectable Perihilar Cholangiocarcinoma. Surgery, 161, 394-404. [Google Scholar] [CrossRef] [PubMed]
[14] Thinkhamrop, K., Khuntikeo, N., Phonjitt, P., et al. (2015) Associ-ation between Diabetes Mellitus and Fatty Liverbased on Ultrasonography Screening in the World’s Highest Cholangio-carcinoma Incidence Region, Northeast Thailand. Asian Pacific Journal of Cancer Prevention, 16, 3931-3936. [Google Scholar] [CrossRef] 
[15] Ozawa, K., Takasan, H., Kitamura, O., et al. (1971) Effect of Ligation of Portal Vein on Liver Mitochondrial Metabolism. The Journal of Biochemistry, 70, 755-764. [Google Scholar] [CrossRef] [PubMed]
[16] Shimizu, Y., Suzuki, H., Nimura, Y., et al. (1995) Elevated Mitochondrial Gene Expression during Rat Liver Regeneration after Portal Vein Ligation. Hepatology, 22, 1222-1229. [Google Scholar] [CrossRef] 
[17] 中国抗癌协会. 肝门部胆管癌规范化诊治专家共识(2015) [J]. 中华肝胆外科杂志, 2015, 21(8): 505-511.
[18] Yi, B., Xu, A.M., Lai, E.C., et al. (2010) Preoperative Portal Vein Embolization for Hilar Cholangiocarcinoma: A Comparative Study. Hepatogastroenterology, 57, 1341-1346.
[19] Qin, Y., Li, C., Ge, X., et al. (2022) MMP2/9 Downregulation Is Responsible for Hepatic Function Recovery in Cirrhotic Rats Following Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy. An-nals of Translational Medicine, 10, 468. [Google Scholar] [CrossRef] [PubMed]
[20] Berardi, G., Guglielmo, N., Colasanti, M., et al. (2022) Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for Advanced Hepatocellular Carcinoma with Macrovascular Invasion. Updates in Surgery, 74, 927-936. [Google Scholar] [CrossRef] [PubMed]
[21] 杜成友, 肖衡. ALPPS在原发性肝癌治疗中的价值和评价[J]. 中国普外基础与临床杂志, 2017, 24(12): 1435-1441.
[22] Schadde, E., Ardiles, V., Slankamenac, K., et al. (2014) ALPPS Offers a Better Chance of Complete Resection in Patients with Primarily Unresectable Liver Tumors Compared with Conventional-Staged Hepatectomies: Results of a Multicenter Analysis. World Journal of Surgery, 38, 1510-1519. [Google Scholar] [CrossRef] [PubMed]
[23] Mansour, J.C., Aloia, T.A., Crane, C.H., et al. (2015) Hilar Cholangiocarcinoma: Expert Consensus Statement. HPB (Oxford), 17, 691-699. [Google Scholar] [CrossRef] [PubMed]
[24] Miyazaki, M., Yoshitomi, H., Miyakawa, S., et al. (2015) Clinical Practice Guidelines for the Management of Biliary Tract Cancers 2015: The 2nd English Edition. Journal of Hepa-to-Biliary-Pancreatic Sciences, 22, 249-273. [Google Scholar] [CrossRef] [PubMed]
[25] 董家鸿, 冯晓彬. 精准外科时代的肝门部胆管癌治疗[J]. 中华消化外科杂志, 2019, 18(4): 307-310.
[26] 李相成, 冯勤超. 肝门部胆管癌的进展与争议[J]. 临床肝胆病杂志, 2019, 35(12): 2632-2637.
[27] Lee, S.G., Song, G.W., Hwang, S., et al. (2010) Surgical Treatment of Hilar Cholangiocarcinoma in the New Era: The Asan Experience. Journal of Hepato-Biliary-Pancreatic Sciences, 17, 476-489. [Google Scholar] [CrossRef] [PubMed]
[28] Sugiura, T., Okamura, Y., Ito, T., et al. (2019) Left Hepatectomy with Combined Resection and Reconstruction of Right Hepatic Artery for Bismuth Type I and II Perihilar Cholangiocar-cinoma.. World Journal of Surgery, 43, 894-901. [Google Scholar] [CrossRef] [PubMed]
[29] Lee, Y., Choi, D., Han, S., et al. (2018) Comparison Analysis of Left-Side versus Right-Side Resection in Bismuth Type III Hilar Cholangiocarcinoma. Annals of Hepa-to-Biliary-Pancreatic Surgery, 22, 350-358. [Google Scholar] [CrossRef] [PubMed]
[30] Matsumoto, N., Ebata, T., Yokoyama, Y., et al. (2014) Role of Ana Tomical Right Hepatic Trisectionectomy for Perihilar Cholangiocarcinoma. British Journal of Surgery, 101, 261-268. [Google Scholar] [CrossRef] [PubMed]
[31] Uesaka, K. (2012) Left Hepatectomy or Left Trisectionectomy with Resection of the Caudate Lobe and Extrahepatic Bile Duct for Hilar Cholangiocarcinoma (with Video). Journal of Hepa-to-Biliary-Pancreatic Sciences, 19, 195-202. [Google Scholar] [CrossRef] [PubMed]
[32] Tsao, J.I., Nimura, Y., Kamiya, J., et al. (2000) Management of Hilar Cholangiocarcinoma: Comparison of an American and a Japanese Experience. Annals of Surgery, 232, 166-174. [Google Scholar] [CrossRef] [PubMed]
[33] Bhutiani, N., Scoggins, C.R., Mcmasters, K.M., et al. (2018) The Impact of Caudate Lobe Resection on Margin Status and Outcomes in Patients with Hilar Cholangiocarcino-ma: A Multi-Institutional Analysis from the US Extrahepatic Biliary Malignancy Consortium. Surgery, 163, 726-731. [Google Scholar] [CrossRef] [PubMed]
[34] Frosio, F., Mocchegiani, F., Conte, G., et al. (2019) Neoadjuvant Therapy in the Treatment of Hilar Cholangiocarcinoma: Review of the Literature. World Journal of Gastrointestinal Sur-gery, 11, 279-286. [Google Scholar] [CrossRef] [PubMed]
[35] Sudan, D., DeRoover, A., Chinnakotla, S., et al. (2002) Radi-ochemotherapy and Transplantation Allow Long-Term Survival for Nonresectable Hilar Cholangiocarcinoma. American Journal of Transplantation, 2, 774-779. [Google Scholar] [CrossRef] [PubMed]
[36] Heimbach, J.K., Haddock, M.G., Alberts, S.R., et al. (2004) Transplantation for Hilar Cholangiocarcinoma. Liver Transplantation, 10, S65-S68. [Google Scholar] [CrossRef] [PubMed]
[37] Hassoun, Z., Gores, G.J. and Rosen, C.B. (2002) Preliminary Experience with Liver Transplantation in Selected Patients with Unresectable Hilar Cholan Giocarcinoma. Surgical Oncology Clinics of North America, 11, 909-921. [Google Scholar] [CrossRef] 

为你推荐